Commoner B, Townsend J, Pake GE: Free radicals in biological materials. Nature. 1954, 174: 689-691. 10.1038/174689a0.
Article
CAS
PubMed
Google Scholar
Harman D: Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956, 11: 298-300.
Article
CAS
PubMed
Google Scholar
Slater TF: Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation. Nature. 1966, 209: 36-40. 10.1038/209036a0.
Article
CAS
PubMed
Google Scholar
McCord JM, Fridovich I: Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969, 244: 6049-6055.
CAS
PubMed
Google Scholar
Slater TF: Free Radical Mechanisms in Tissue Injury. 1972, London, UK: Pion Ltd
Google Scholar
Harman D: The aging process. Proc Natl Acad Sci USA. 1981, 78: 7124-7128. 10.1073/pnas.78.11.7124.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cadenas E: Biochemistry of oxygen toxicity. Ann Rev Biochem. 1989, 58: 79-110. 10.1146/annurev.bi.58.070189.000455.
Article
CAS
PubMed
Google Scholar
Cadenas E, Davies KJ: Mitochondrial free radical generation, oxidative stress and aging. Free Radic Biol Med. 2000, 29: 222-230. 10.1016/S0891-5849(00)00317-8.
Article
CAS
PubMed
Google Scholar
West JD, Marnett LJ: Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol. 2006, 19: 173-194. 10.1021/tx050321u.
Article
CAS
PubMed
Google Scholar
White AA, Crawford KM, Patt CS, Lad PJ: Activation of soluble guanylate cyclase from rat lung by incubation or by hydrogen peroxide. J Biol Chem. 1976, 251: 7304-7312.
CAS
PubMed
Google Scholar
Mittal CK, Murad F: Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation. Proc Natl Acad Sci USA. 1977, 74: 4360-4364. 10.1073/pnas.74.10.4360.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ignarro LJ, Kadowitz PJ: The pharmacological and physiological role of cGMP in vascular smooth muscle relaxation. Ann Pharmacol Toxicol. 1985, 25: 171-191. 10.1146/annurev.pa.25.040185.001131.
Article
CAS
Google Scholar
Radomski MW, Palmer RMJ, Moncada S: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987, 92: 639-646.
Article
PubMed Central
CAS
PubMed
Google Scholar
Thannickal VJ, Farnburg BL: Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L1005-L1028.
CAS
PubMed
Google Scholar
Dröge W: Free radicals in the physiological control of cell function. Physiol Rev. 2002, 82: 47-95.
Article
PubMed
Google Scholar
Soberman RJ: The expanding network of redox signaling: new observations, complexities, and perspectives. J Clin Invest. 2003, 111: 571-574.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chiarugi P, Cirri P: Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci. 2003, 28: 509-514. 10.1016/S0968-0004(03)00174-9.
Article
CAS
PubMed
Google Scholar
D'Autrèaux B, Toledano MB: ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007, 8: 813-824. 10.1038/nrm2256.
Article
PubMed
CAS
Google Scholar
Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991, 11: 81-128. 10.1016/0891-5849(91)90192-6.
Article
CAS
PubMed
Google Scholar
Dianzani MU: 4-Hydroxynonenal and cell signaling. Free Rad Res. 1998, 28: 553-560. 10.3109/10715769809065811.
Article
CAS
Google Scholar
Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU: 4-Hydroxynonenal as a biological signal: molecular bases and pathophysiological implication. Antioxid Redox Signal. 1999, 1: 255-284. 10.1089/ars.1999.1.3-255.
Article
CAS
PubMed
Google Scholar
Poli G, Schaur RJ: 4-Hydroxynonenal in the phatomechanisms of oxidative stress. IUBMB Life. 2000, 50: 315-321. 10.1080/15216540051081092.
Article
CAS
PubMed
Google Scholar
Uchida K: 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 2003, 42: 318-343. 10.1016/S0163-7827(03)00014-6.
Article
CAS
PubMed
Google Scholar
Witztum JL, Steinberg D: The oxidative modification hypothesis of atherosclerosis: does it hold for humans?. Trends Cardiovasc Med. 2001, 11: 93-102. 10.1016/S1050-1738(01)00111-6.
Article
CAS
PubMed
Google Scholar
Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2003, 23: 599-622. 10.1210/er.2001-0039.
Article
CAS
Google Scholar
Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H: Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003, 91: 7A-11A. 10.1016/S0002-9149(02)03144-2.
Article
CAS
PubMed
Google Scholar
Pennathur S, Heinecke JW: Oxidative stress and endothelial dysfunction in vascular disease. Curr Diab Rep. 2007, 7: 257-264. 10.1007/s11892-007-0041-3.
Article
CAS
PubMed
Google Scholar
Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, Yamasaki Y: Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal. 2007, 9: 355-366. 10.1089/ars.2006.1465.
Article
CAS
PubMed
Google Scholar
Papaharalambus CA, Griendling KK: Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med. 2007, 17: 48-54. 10.1016/j.tcm.2006.11.005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Marnett LJ, Riggins JN, West JD: Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest. 2003, 111: 583-593.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wu WS: The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006, 25: 695-705. 10.1007/s10555-006-9037-8.
Article
CAS
PubMed
Google Scholar
Klein JA, Ackerman SL: Oxidative stress, cell cycle and neurodegeneration. J Clin Invest. 2003, 111: 785-793.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mattson MP: Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal. 2006, 8: 1997-2006. 10.1089/ars.2006.8.1997.
Article
CAS
PubMed
Google Scholar
Zhu X, Su B, Wang X, Smith MA, Perry G: Causes of oxidative stress in Alzheimer diseases. Cell Mol Life Sci. 2007, 64: 2202-2210. 10.1007/s00018-007-7218-4.
Article
CAS
PubMed
Google Scholar
Parola M, Robino G: Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001, 35: 297-306. 10.1016/S0168-8278(01)00142-8.
Article
CAS
PubMed
Google Scholar
Zamara E, Novo E, Parola M: Oxidative stress and liver fibrosis: from liver injury to the modulation of cell signaling and response. Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights. Edited by: Ali S, Mann DA, Friedman SL. 2004, Enfield, NH: Science Publishers USA;, 1: 93-114.
Google Scholar
Farrell GC, Larter CZ: Nonalcoholic fatty liver diseases: from steatosis to cirrhosis. Hepatology. 2006, S99-S112. 10.1002/hep.20973. Suppl 1
Albano E: Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 2006, 65: 278-280. 10.1079/PNS2006496.
Article
CAS
PubMed
Google Scholar
Rahman I, Biswas SK, Kode A: Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol. 2006, 533: 222-239. 10.1016/j.ejphar.2005.12.087.
Article
CAS
PubMed
Google Scholar
Rahman I, Yang SR, Biswas SK: Current concepts of redox signaling in the lungs. Antioxid Redox Signal. 2006, 8: 681-689. 10.1089/ars.2006.8.681.
Article
CAS
PubMed
Google Scholar
Cho HY, Reddy SP, Kleeberger SR: Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 2006, 8: 76-87. 10.1089/ars.2006.8.76.
Article
CAS
PubMed
Google Scholar
Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. 1999, Oxford, UK: Oxford University Press
Google Scholar
Babior BM: NADPH oxidase: an update. Blood. 1999, 93: 1464-1476.
CAS
PubMed
Google Scholar
Vignais PV: The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci. 2002, 59: 1428-1459. 10.1007/s00018-002-8520-9.
Article
CAS
PubMed
Google Scholar
Genestra M: Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 2007, 19: 1807-1819. 10.1016/j.cellsig.2007.04.009.
Article
CAS
PubMed
Google Scholar
Lambeth JD: Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med. 2007, 43: 332-347. 10.1016/j.freeradbiomed.2007.03.027.
Article
PubMed Central
CAS
PubMed
Google Scholar
De Minicis S, Bataller R, Brenner DA: NADPH oxidase in the liver: defensive, offensive, or fibrogenic?. Gastroenterology. 2006, 131: 272-275. 10.1053/j.gastro.2006.05.048.
Article
CAS
PubMed
Google Scholar
De Minicis S, Brenner DA: NOX in liver fibrosis. Arch Biochem Biophys. 2007, 462: 266-272. 10.1016/j.abb.2007.04.016.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chiarugi P, Fiaschi T: Redox signalling in anchorage-dependent cell growth. Cell Signal. 2007, 19: 672-682. 10.1016/j.cellsig.2006.11.009.
Article
CAS
PubMed
Google Scholar
Pritsos CA: Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact. 2000, 129: 195-208. 10.1016/S0009-2797(00)00203-9.
Article
CAS
PubMed
Google Scholar
Vazquez-Vivar J, Kalyanaramam B: Generation of superoxide from nitric oxide synthase. FEBS. 2000, 481: 304-307. 10.1016/S0014-5793(00)02001-9.
Article
Google Scholar
Rojkind M, Domininguez-Rosales JA, Nieto N, Greenwel P: Role of hydrogen peroxide and oxidative stress in healing responses. Cell Mol Life Sci. 2002, 59: 1872-1891. 10.1007/PL00012511.
Article
CAS
PubMed
Google Scholar
Morrow JD, Awad JA, Kato T, Takahashi K, Badr KF, Roberts LJ, Burk RF: Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Invest. 1992, 92: 2502-2507. 10.1172/JCI116143.
Article
Google Scholar
Halliwell B, Whiteman M: Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol. 2004, 142: 231-255. 10.1038/sj.bjp.0705776.
Article
PubMed Central
CAS
PubMed
Google Scholar
Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C: Isoprostanes and hepatic fibrosis. Mol Aspects Med. 2008, 29: 43-49. 10.1016/j.mam.2007.09.011.
Article
CAS
PubMed
Google Scholar
Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C: F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med. 2008, 44: 247-256. 10.1016/j.freeradbiomed.2007.10.004.
Article
CAS
PubMed
Google Scholar
Poli G, Parola M: Oxidative damage and fibrogenesis. Free Radic Biol Med. 1997, 22: 287-305. 10.1016/S0891-5849(96)00327-9.
Article
CAS
PubMed
Google Scholar
Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007, 87: 315-424. 10.1152/physrev.00029.2006.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sase K, Michel T: Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med. 1997, 7: 28-37. 10.1016/S1050-1738(96)00121-1.
Article
CAS
PubMed
Google Scholar
Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK: Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin sensitive K-channel by a cGMP-dependent protein kinase. Proc Natl Acad Sci USA. 1994, 91: 7583-7587. 10.1073/pnas.91.16.7583.
Article
PubMed Central
CAS
PubMed
Google Scholar
Beckman JS: Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996, 9: 836-844. 10.1021/tx9501445.
Article
CAS
PubMed
Google Scholar
Beckman JS: The physiological and pathological chemistry of nitric oxide. Nitric Oxide: Principles and Actions. Edited by: Lancaster JR, Orlando FL. 1996, San Diego, CA: Academic Press, 1-82.
Chapter
Google Scholar
Butler AR, Megson IL, Wright PG: Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta. 1998, 1425: 168-176.
Article
CAS
PubMed
Google Scholar
Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. 1989, Oxford, UK: Oxford University Press, 2
Google Scholar
Young IS, Woodside JV: Antioxidant in health and disease. J Clin Pathol. 2001, 54: 176-186. 10.1136/jcp.54.3.176.
Article
PubMed Central
CAS
PubMed
Google Scholar
Berndt C, Lillig CH, Holmgren A: Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol. 2007, 292: 1227-1236. 10.1152/ajpheart.01162.2006.
Article
CAS
Google Scholar
Grune T, Reinheckel T, Davies KJ: Degradation of oxidized proteins in mammalian cells. FASEB J. 1997, 11: 526-534.
CAS
PubMed
Google Scholar
Bader N, Grune T: Protein oxidation and proteolysis. Biol Chem. 2006, 387: 1351-1355. 10.1515/BC.2006.169.
Article
CAS
PubMed
Google Scholar
Jung T, Bader N, Grune T: Oxidized proteins: intracellular distribution and recognition by the proteasome. Arc Bioch Bioph. 2007, 462: 231-237. 10.1016/j.abb.2007.01.030.
Article
CAS
Google Scholar
Wu WS, Wu JR, Hu CT: Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev. 2006, 27: 303-314. 10.1007/s10555-008-9112-4.
Article
CAS
Google Scholar
Liu H, Colavitti R, Rovira II, Finkel T: Redox-dependent transcriptional regulation. Circ Res. 2005, 97: 967-974. 10.1161/01.RES.0000188210.72062.10.
Article
CAS
PubMed
Google Scholar
Fritz G, Grosch S, Tomicic M, Kaina B: APE/Ref-1 and the mammalian response to genotoxic stress. Toxicology. 2003, 193: 67-78. 10.1016/S0300-483X(03)00290-7.
Article
CAS
PubMed
Google Scholar
Tell G, Damante G, Caldwell D, Kelley MR: The intracellular localization of APE/Ref-1: more than a passive phenomenon?. Antioxid Redox Signal. 2005, 7: 367-384. 10.1089/ars.2005.7.367.
Article
CAS
PubMed
Google Scholar
Shafritz DA, Oertel M, Menthena A, Nierhoff D, Dabeva MD: Liver stem cells and the prospects for liver reconstitution by transplanted cells. Hepatology. 2006, 43: S89-S98. 10.1002/hep.21047.
Article
CAS
PubMed
Google Scholar
Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to issue injury. J Biol Chem. 2000, 275: 2247-2250. 10.1074/jbc.275.4.2247.
Article
CAS
PubMed
Google Scholar
Pinzani M, Marra F: Cytokine receptor and signalling in hepatic stellate cells. Semin Liv Dis. 2001, 21: 397-417. 10.1055/s-2001-17554.
Article
CAS
Google Scholar
Friedman SL: Liver fibrosis: from bench to bedside. J Hepatol. 2003, 38: S28-S53. 10.1016/S0168-8278(02)00429-4.
Article
Google Scholar
Pinzani M, Rombouts K: Liver fibrosis-from the bench to clinical targets. Dig Liver Dis. 2004, 36: 231-242. 10.1016/j.dld.2004.01.003.
Article
CAS
PubMed
Google Scholar
Bataller R, Brenner DA: Liver fibrosis. J Clin Invest. 2005, 115: 109-118.
Google Scholar
Friedman SL: Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutics implications. Nat Clin Pract Gastroenterol Hepatol. 2004, 1: 98-105. 10.1038/ncpgasthep0055.
Article
PubMed
Google Scholar
Friedman SL: Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008, 88: 125-172. 10.1152/physrev.00013.2007.
Article
PubMed Central
CAS
PubMed
Google Scholar
Parola M, Marra F, Pinzani M: Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Asp Med. 2008, 29: 58-66. 10.1016/j.mam.2007.09.002.
Article
CAS
Google Scholar
Medina J, Arroyo AG, Sánchez-Madrid F, Moreno-Otero R: Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004, 39: 1185-1195. 10.1002/hep.20193.
Article
CAS
PubMed
Google Scholar
Desmet VJ, Roskams T: Cirrhosis reversal: a duel between dogma and myth. J Hepatol. 2004, 40: 860-867. 10.1016/j.jhep.2004.03.007.
Article
PubMed
Google Scholar
Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T: Hepatic stellate cells/myofibroblast subpopulation in fibrotic human and rat livers. J Hepatol. 2002, 36: 200-209. 10.1016/S0168-8278(01)00260-4.
Article
PubMed
Google Scholar
Cassiman D, Roskams T: Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cells research. J Hepatol. 2002, 37: 527-535. 10.1016/S0168-8278(02)00263-5.
Article
PubMed
Google Scholar
Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR: A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology. 2004, 126: 955-963. 10.1053/j.gastro.2004.02.025.
Article
PubMed
Google Scholar
Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP, Forbes SJ: The bone marrow functionally contributes to liver fibrosis. Gastroenterology. 2006, 130: 1807-1821. 10.1053/j.gastro.2006.01.036.
Article
PubMed
Google Scholar
Valfrè di Bonzo L, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, Sanavio F, Cannito S, Zamara E, Bertero M, Davit A, Francica S, Novelli F, Colombatto S, Fagioli F, Parola M: Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut. 2008, 57: 223-231. 10.1136/gut.2006.111617.
Article
PubMed
CAS
Google Scholar
Forbes SJ: Stem cell therapy for chronic liver disease – choosing the right tools for the job. Gut. 2008, 57: 153-155. 10.1136/gut.2007.134247.
Article
PubMed
Google Scholar
Iredale J: Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007, 117: 539-548. 10.1172/JCI30542.
Article
PubMed Central
CAS
PubMed
Google Scholar
Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, Vizzuti F, Anania FA, Milani S, Rombouts K, Laffi G, Pinzani M, Marra F: Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005, 42: 1339-1348. 10.1002/hep.20965.
Article
CAS
PubMed
Google Scholar
Novo E, Cannito S, Zamara E, Valfrè di Bonzo L, Caligiuri A, Cravanzola C, Compagnone A, Colombatto S, Marra F, Pinzani M, Parola M: Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol. 2007, 170: 1942-1953. 10.2353/ajpath.2007.060887.
Article
PubMed Central
CAS
PubMed
Google Scholar
Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M: Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut. 2006, 55: 1174-1182. 10.1136/gut.2005.082701.
Article
PubMed Central
CAS
PubMed
Google Scholar
El-Sharkawy AM, Oakley F, Mann D: The role and regulation of hepatic stellate cells apoptosis in reversal of liver fibrosis. Apoptosis. 2005, 10: 927-939. 10.1007/s10495-005-1055-4.
Article
CAS
Google Scholar
Leist M, Jäättelä M: Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001, 2: 589-598. 10.1038/35085008.
Article
CAS
PubMed
Google Scholar
Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ: Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest. 2003, 83: 655-663.
Article
CAS
PubMed
Google Scholar
Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ: Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology. 2002, 123: 1323-1330. 10.1053/gast.2002.35953.
Article
CAS
PubMed
Google Scholar
Den Hertog J, Groen A, Wijk Van der T: Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys. 2005, 434: 11-15. 10.1016/j.abb.2004.05.024.
Article
CAS
PubMed
Google Scholar
Tonks KN: Redox redux: revisiting PTPs and the control of cell signaling. Cell. 2005, 121: 667-670. 10.1016/j.cell.2005.05.016.
Article
CAS
PubMed
Google Scholar
Tonks NK: Protein tyrosine phosphatases: from genes, to function, to disease. Mol Cell Biol. 2006, 7: 833-845.
CAS
Google Scholar
Weiss FU, Daub H, Ullrich A: Novel mechanisms of RTK signal generation. Curr Opin Genet Dev. 1997, 7: 80-86. 10.1016/S0959-437X(97)80113-X.
Article
CAS
PubMed
Google Scholar
Gotoh Y, Cooper JA: Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction. J Biol Chem. 1998, 273: 17477-17482. 10.1074/jbc.273.28.17477.
Article
CAS
PubMed
Google Scholar
Liu H, Nishitoh H, Ichijo H, Kyriakis JM: Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol. 2000, 20: 2198-2208. 10.1128/MCB.20.6.2198-2208.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zingg JM: Modulation of signal transduction by vitamin E. Mol Aspects Med. 2007, 28: 481-506. 10.1016/j.mam.2006.12.009.
Article
CAS
PubMed
Google Scholar
Schreck R, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of NFκB transcription factor and HIV-1. Trends Cell Biol. 1991, 1: 39-42. 10.1016/0962-8924(91)90072-H.
Article
CAS
PubMed
Google Scholar
Temkin V, Karin M: From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odyssey. Immunol Rev. 2007, 220: 8-21. 10.1111/j.1600-065X.2007.00560.x.
Article
CAS
PubMed
Google Scholar
Luo JL, Kamata H, Karin M: IKK/NF-kappaB signaling: balancing life and death – a new approach to cancer therapy. J Clin Invest. 2005, 115: 2625-2632. 10.1172/JCI26322.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bonizzi G, Karin M: The two NF-kappaB activation pathways and their role in innate and adaptative immunity. Trends Immunol. 2004, 25: 280-288. 10.1016/j.it.2004.03.008.
Article
CAS
PubMed
Google Scholar
Gloire G, Legrand-Poels S, Piette J: NF-κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006, 72: 1493-1505. 10.1016/j.bcp.2006.04.011.
Article
CAS
PubMed
Google Scholar
Pietrangelo A: Hereditary hemochromatosis-a new look at an old disease. N Engl J Med. 2004, 350: 2383-2397. 10.1056/NEJMra031573.
Article
CAS
PubMed
Google Scholar
Pietrangelo A: Hemochromatosis: an endocrine liver disease. Hepatology. 2007, 46: 1291-1301. 10.1002/hep.21886.
Article
CAS
PubMed
Google Scholar
Philippe MA, Ruddell RG, Ramm GA: Role of Iron in hepatic fibrosis: one pieces in the puzzle. World J Gastroenterol. 2007, 13: 4746-4754.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pietrangelo A: Hemochromatosis. Gut. 2003, 52: ii23-ii30. 10.1136/gut.52.suppl_2.ii23.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pietrangelo A: Hemochromatosis gene modifies corse of hepatitis C viral infection. Gastroenterology. 2003, 124: 1509-1523. 10.1016/S0016-5085(03)00275-0.
Article
CAS
PubMed
Google Scholar
Martinelli AL, Ramalho LN, Zucoloto S: Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease. J Gastroenterol Hepatol. 2004, 19: 91-98. 10.1111/j.1440-1746.2004.03255.x.
Article
PubMed
Google Scholar
Rigamonti C, Andorno S, Maduli E, Morelli S, Pittau S, Nicosia G, Boldorini R, Sartori M: Iron, hepatic stellate cells and fibrosis in chronic hepatitis C. Eur J Clin Invest. 2002, 32: 28-35. 10.1046/j.1365-2362.2002.0320s1028.x.
Article
PubMed
Google Scholar
Bridle K, Cheung TK, Murphy T, Walters M, Anderson G, Crawford DG, Fletcher LM: Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res. 2006, 30: 106-112. 10.1111/j.1530-0277.2006.00002.x.
Article
CAS
PubMed
Google Scholar
Brittenham GM: Iron chelators and iron toxicity. Alcohol. 2003, 30: 151-158. 10.1016/S0741-8329(03)00101-0.
Article
CAS
PubMed
Google Scholar
Pietrangelo A, Borella F, Casalgrandi G, Montosi G, Ceccarelli D, Gallesi D, Giovannini F, Gasparetto A, Masini A: Antioxidant activity of sylibin in vivo during chronic iron overload in rats. Gastroenterology. 1995, 109: 1941-1949. 10.1016/0016-5085(95)90762-9.
Article
CAS
PubMed
Google Scholar
Pietrangelo A, Gualdi R, Casalgrandi G, Montosi G, Venturi E: Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest. 1995, 95: 1824-1831. 10.1172/JCI117861.
Article
PubMed Central
CAS
PubMed
Google Scholar
Eaton JW, Qian M: Molecular bases of cellular iron toxicity. Free Radic Biol Med. 2002, 32: 833-840. 10.1016/S0891-5849(02)00772-4.
Article
CAS
PubMed
Google Scholar
Papanikolaou G, Pantopoulos K: Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005, 202: 199-211. 10.1016/j.taap.2004.06.021.
Article
CAS
PubMed
Google Scholar
Ramm GA, Ruddell RG: Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005, 25: 433-449. 10.1055/s-2005-923315.
Article
CAS
PubMed
Google Scholar
Cairo G, Recalcati S, Pietrangelo A, Minotti G: The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med. 2002, 32: 1237-1243. 10.1016/S0891-5849(02)00825-0.
Article
CAS
PubMed
Google Scholar
Llanos RM, Mercer JF: The molecular basis of copper homeostasis in copper-related disorders. DNA Cell Biol. 2002, 21: 259-270. 10.1089/104454902753759681.
Article
CAS
PubMed
Google Scholar
Tao TY, Gitlin JD: Hepatic copper metabolism: insights from genetic disease. Hepatology. 2003, 37: 1241-1247. 10.1053/jhep.2003.50281.
Article
CAS
PubMed
Google Scholar
Sokol RJ, Winklhofer-Roob BM, Deveraux MW, McKim JM: Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 1995, 109: 1249-1256. 10.1016/0016-5085(95)90585-5.
Article
CAS
PubMed
Google Scholar
Novo E, Zamara E, Valfre di Bonzo L, Parola M: Modulation of cell death, signal transduction and cell response by oxidative stress in the progression of chronic liver diseases. Liver Cirrhosis Research. Edited by: Burns JL. Hauppauge, NY: Nova Science Publishers.
Day CP: Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 2006, 26: 1021-1028. 10.1111/j.1478-3231.2006.01323.x.
Article
CAS
PubMed
Google Scholar
Boyer N, Marcellin P: Pathogenesis, diagnosis and management of hepatitis C. J Hepatol. 2000, 32: 98-112. 10.1016/S0168-8278(00)80419-5.
Article
CAS
PubMed
Google Scholar
Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchinson J, Albrecht J: Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol. 2001, 34: 764-767. 10.1016/S0168-8278(01)00055-1.
Article
Google Scholar
Arteel GE: Oxidant and antioxidant in alcohol-induced liver disease. Gastroenterology. 2003, 124: 778-790. 10.1053/gast.2003.50087.
Article
CAS
PubMed
Google Scholar
Nanji AA: Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol. 2004, 34: 21-25. 10.1016/j.alcohol.2004.08.005.
Article
CAS
PubMed
Google Scholar
Albano E: Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med. 2008, 29: 9-16. 10.1016/j.mam.2007.09.004.
Article
CAS
PubMed
Google Scholar
Dey A, Cederbaum AI: Alcohol and oxidative liver injury. Hepatology. 2006, 43: S63-S74. 10.1002/hep.20957.
Article
CAS
PubMed
Google Scholar
Parola M, Robino G, Bordone R, Leonarduzzi G, Casini A, Pinzani M, Neve E, Bellomo G, Dianzani MU, Ingelman-Sundberg M, Albano E: Detection of cytochrome P450A (CYP3A) in human hepatic stellate cells. Biochem Biophys Res Commun. 1997, 238: 420-424. 10.1006/bbrc.1997.7307.
Article
CAS
PubMed
Google Scholar
Powell EE, Jonsson JR, Clouston AD: Steatosis: co-factor in other liver diseases. Hepatology. 2005, 42: 5-13. 10.1002/hep.20750.
Article
CAS
PubMed
Google Scholar
Pessayre D, Fromenty B: NASH: a mithocondrial disease. J Hepatol. 2005, 42: 928-940. 10.1016/j.jhep.2005.03.004.
Article
CAS
PubMed
Google Scholar
Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA: Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest. 2004, 113: 1277-1287.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, Dede J, French SW: CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol. 2006, 81: 191-201. 10.1016/j.yexmp.2006.07.007.
Article
CAS
PubMed
Google Scholar
Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346: 1221-1231. 10.1056/NEJMra011775.
Article
CAS
PubMed
Google Scholar
Parekh S, Anania FA: Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007, 132: 2191-2207. 10.1053/j.gastro.2007.03.055.
Article
CAS
PubMed
Google Scholar
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic sindrome. Hepatology. 2003, 38: 536.
Article
Google Scholar
Tilg H, Hotamisligil GS: Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology. 2006, 131: 934-945. 10.1053/j.gastro.2006.05.054.
Article
CAS
PubMed
Google Scholar
Day CP, James OF: Steatohepatitis: a tale of two 'hits'?. Gastroenterology. 1998, 114: 842-845. 10.1016/S0016-5085(98)70599-2.
Article
CAS
PubMed
Google Scholar
Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M: Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005, 48: 634-642. 10.1007/s00125-005-1682-x.
Article
CAS
PubMed
Google Scholar
Reid AE: Nonalcoholic steatohepatitis. Gastroenterology. 2001, 121: 710-723. 10.1053/gast.2001.27126.
Article
CAS
PubMed
Google Scholar
Robertson G, Leclercq I, Farrell GC: Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol. 2001, 281: G1135-1139.
CAS
PubMed
Google Scholar
Mehta K, Van Thiel DH, Shah N, Mobarhan S: Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev. 2002, 60: 289-293. 10.1301/002966402320387224.
Article
PubMed
Google Scholar
Day CP: Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?. Gut. 2002, 50: 585-588. 10.1136/gut.50.5.585.
Article
PubMed Central
CAS
PubMed
Google Scholar
Leclerq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR: CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non alcoholic steatohepatitis. J Clin Invest. 2000, 105: 1067-1075. 10.1172/JCI8814.
Article
Google Scholar
Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C: Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology. 1998, 27: 128-133. 10.1002/hep.510270121.
Article
CAS
PubMed
Google Scholar
Browning JD, Horton JD: Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004, 114: 147-152.
Article
PubMed Central
CAS
PubMed
Google Scholar
Serviddio G, Sastre J, Bellanti F, Vina J, Vendemmiale G, Altomare E: Mitochondrial involvement in non-alcoholic steatohepatitis. Mol Asp Med. 2008, 29: 22-35. 10.1016/j.mam.2007.09.014.
Article
CAS
Google Scholar
Crabb DW, Liangpunsakul S: Alcohol and lipid metabolism. J Gastroenterol Hepatol. 2006, 21: S56-S60. 10.1111/j.1440-1746.2006.04582.x.
Article
CAS
PubMed
Google Scholar
Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a casual role in multiple forms of insulin resistance. Nature. 2006, 440: 944-948. 10.1038/nature04634.
Article
CAS
PubMed
Google Scholar
Bloch-Damti A, Basham N: Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal. 2005, 7: 1553-1567. 10.1089/ars.2005.7.1553.
Article
CAS
PubMed
Google Scholar
Shattemberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ: Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signalling. J Biol Chem. 2005, 280: 9887-9894. 10.1074/jbc.M410310200.
Article
CAS
Google Scholar
Xu Z, Chen L, Leung L, Yen TSB, Lee C, Chan JY: Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA. 2005, 102: 4120-4125. 10.1073/pnas.0500660102.
Article
PubMed Central
CAS
PubMed
Google Scholar
Parola M, Novo E: Nrf1 gene expression in the liver: a single gene linking oxidative stress to NAFLD, NASH and hepatic tumours. J Hepatol. 2005, 43: 1096-1097. 10.1016/j.jhep.2005.09.008.
Article
CAS
Google Scholar
Loguercio C, Federico A: Oxidative stress in viral and alcoholis hepatitis. Free Radic Biol Med. 2003, 34: 1-10. 10.1016/S0891-5849(02)01167-X.
Article
CAS
PubMed
Google Scholar
Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyosh H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K: Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001, 61: 4365-4370.
CAS
PubMed
Google Scholar
Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002, 122: 366-375. 10.1053/gast.2002.30983.
Article
CAS
PubMed
Google Scholar
Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM: Steatosis and liver cancer in transgenic mice expressing the structural and non-structural proteins of hepatitis C virus. Gastroenterology. 2002, 122: 352-365. 10.1053/gast.2002.31001.
Article
CAS
PubMed
Google Scholar
Gong G, Waris G, Tanveer R, Siddiqui A: Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA. 2001, 98: 9599-604. 10.1073/pnas.171311298.
Article
PubMed Central
CAS
PubMed
Google Scholar
Qadri I, Iwahashi M, Capasso JM, Hopkin MW, Flores S, Schaack J, Simon FR: Induced oxidative stress and activated expression of manganese superoxide dismutase (MnSOD) during hepatitis C virus replication: Role of JNK, p38MAPK AP-1. Biochem J. 2004, 378: 919-928. 10.1042/BJ20031587.
Article
PubMed Central
CAS
PubMed
Google Scholar
Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A: Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkBα and its degradation by calpain protease. J Biol Chem. 2003, 278: 40778-40787. 10.1074/jbc.M303248200.
Article
CAS
PubMed
Google Scholar
Seronello S, Sheikh MY, Choi J: Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Rad Biol Med. 2007, 43: 869-882. 10.1016/j.freeradbiomed.2007.05.036.
Article
CAS
PubMed
Google Scholar
Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, Furutani T, Sakai A, Okuda M, Hidaka I, Okita K, Sakaida I: Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology. 2008, 134: 226-238. 10.1053/j.gastro.2007.10.011.
Article
CAS
PubMed
Google Scholar
Alpini G, McGill JM, La Russo NF: The pathobiology of biliary epithelia. Hepatology. 2002, 35: 1256-1268. 10.1053/jhep.2002.33541.
Article
CAS